Category Archives: Pricing and Value

Clouds on the Horizon, Part 2

On Friday, I discussed the fact that there are some clouds on the horizon for the image of the pharmaceutical industry as the Medicare Drug Benefit matures. Today, I’m looking further out on the horizon.  The Pharmaceutical Research and Manufacturers … Continue reading

Posted in Marketing, Pricing and Value | Comments Off on Clouds on the Horizon, Part 2

Generics and Pricing

I almost missed this from the FDA.  It is common knowledge that generic drugs usually mean a lower price for a chemical therapy.  That is why the Hatch-Waxman Act exists.  However, a study released by the FDA on April 4, … Continue reading

Posted in Pricing and Value | Comments Off on Generics and Pricing

A Presidential Call for Transparency in Healthcare

Recently the President has been calling for more transparency in healthcare pricing.  Initially he is talking about how hospitals and healthcare plans operate.  But as the realities of Medicare Part D begin showing themselves, that call may broaden to the … Continue reading

Posted in Pharma Industry Image, Pricing and Value | Comments Off on A Presidential Call for Transparency in Healthcare